Sherif Farag

  • 4139 Citations
  • 32 h-Index
1977 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

Filter
Review article
2020

Vaccine and cell-based therapeutic approaches in acute myeloid leukemia

Agrawal, V., Gbolahan, O. B., Stahl, M., Zeidan, A. M., Abu Zaid, M., Farag, S. S. & Konig, H., 2020, In : Current cancer drug targets. 20, 7, p. 473-489 17 p.

Research output: Contribution to journalReview article

2017

Immunotherapeutic concepts to target acute myeloid leukemia: Focusing on the role of monoclonal antibodies, hypomethylating agents and the leukemic microenvironment

Gbolahan, O. B., Zeidan, A. M., Stahl, M., Zaid, M. A., Farag, S., Paczesny, S. & Konig, H., Aug 2017, In : International journal of molecular sciences. 18, 8, 1660.

Research output: Contribution to journalReview article

14 Scopus citations
2013
16 Scopus citations
2011
1 Scopus citations

The potential role of Aurora kinase inhibitors in haematological malignancies

Farag, S. S., Dec 2011, In : British journal of haematology. 155, 5, p. 561-579 19 p.

Research output: Contribution to journalReview article

43 Scopus citations
2005

DC therapy? Let the natural killer answer

Farag, S. S., Sep 15 2005, In : Blood. 106, 6, 1 p.

Research output: Contribution to journalReview article

1 Scopus citations
2003

Biology and clinical impact of human natural killer cells

Farag, S. S., VanDeusen, J. B., Fehniger, T. A. & Caligiuri, M. A., Jul 2003, In : International Journal of Hematology. 78, 1, p. 7-17 11 p.

Research output: Contribution to journalReview article

78 Scopus citations

New directions in natural killer cell-based immunotherapy of human cancer

Farag, S. S., Fehniger, T. A., Becknell, B., Blaser, B. W. & Caligiuri, M. A., Apr 1 2003, In : Expert Opinion on Biological Therapy. 3, 2, p. 237-250 14 p.

Research output: Contribution to journalReview article

31 Scopus citations

Radiation-free regimens result in similar outcomes of allogeneic hematopoietic progenitor cell transplation in patients aged ≥ 50 years compared to young adults with low-risk disease

Farag, S. S., Elder, P. J., Marcucci, G., Penza, S., Mrozek, E., Molina, A., Lin, T., Avalos, B. R. & Copelan, E., Jan 1 2003, In : Bone marrow transplantation. 31, 2, p. 87-93 7 p.

Research output: Contribution to journalReview article

12 Scopus citations
2002

Chronic lymphocytic leukemia.

Kay, N. E., Hamblin, T. J., Jelinek, D. F., Dewald, G. W., Byrd, J. C., Farag, S., Lucas, M. & Lin, T., 2002, In : Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. p. 193-213 21 p.

Research output: Contribution to journalReview article

74 Scopus citations

Natural killer cell receptors: New biology and insights into the graft-versus-leukemia effect

Farag, S. S., Fehniger, T. A., Ruggeri, L., Velardi, A. & Caligiuri, M. A., Sep 15 2002, In : Blood. 100, 6, p. 1935-1947 13 p.

Research output: Contribution to journalReview article

398 Scopus citations